These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20220056)

  • 1. Apelin in plasma and vitreous and in fibrovascular retinal membranes of patients with proliferative diabetic retinopathy.
    Tao Y; Lu Q; Jiang YR; Qian J; Wang JY; Gao L; Jonas JB
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4237-42. PubMed ID: 20220056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apelin in epiretinal fibrovascular membranes of patients with retinopathy of prematurity and the changes after intravitreal bevacizumab.
    Zhang Y; Jiang YR; Lu Q; Yin H; Tao Y
    Retina; 2013 Mar; 33(3):613-20. PubMed ID: 23296045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy.
    Qian J; Lu Q; Tao Y; Jiang YR
    Retina; 2011 Jan; 31(1):161-8. PubMed ID: 20890241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
    Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenomedullin and leptin levels in diabetic retinopathy and retinal diseases.
    Er H; Doğanay S; Ozerol E; Yürekli M
    Ophthalmologica; 2005; 219(2):107-11. PubMed ID: 15802936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular expression of serum amyloid a and interleukin-6 in proliferative diabetic retinopathy.
    Ma Y; Tao Y; Lu Q; Jiang YR
    Am J Ophthalmol; 2011 Oct; 152(4):678-685.e2. PubMed ID: 21704966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy.
    George B; Chen S; Chaudhary V; Gonder J; Chakrabarti S
    Curr Eye Res; 2009 Feb; 34(2):134-44. PubMed ID: 19219685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of vitreous and plasma levels of vascular endothelial growth factor, interleukin-6 and hepatocyte growth factor in diabetic and non-diabetic retinal detachment cases.
    Kocak N; Alacacioglu I; Kaynak S; Ozcan MA; Celik O; Yuksel F; Piskin O; Oner H; Saatci AO; Ergin M
    Ann Ophthalmol (Skokie); 2010; 42 Spec No():10-4. PubMed ID: 21138144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H; Kishi S; Kotajima N; Murakami M
    Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
    Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
    Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor (VEGF).
    Nicoletti VG; Nicoletti R; Ferrara N; Meli G; Reibaldi M; Reibaldi A
    Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):209-14. PubMed ID: 12845559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
    N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
    Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
    Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory cytokines and angiogenic and antiangiogenic factors in vitreous of patients with proliferative diabetic retinopathy and Eales' disease (ED).
    Querques G; Delle Noci N
    Retina; 2009 Jan; 29(1):121-3; author reply 123. PubMed ID: 18936719
    [No Abstract]   [Full Text] [Related]  

  • 17. Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy.
    Ishida S; Shinoda K; Kawashima S; Oguchi Y; Okada Y; Ikeda E
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1649-56. PubMed ID: 10845581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor, SP1, in epiretinal membranes of patients with proliferative diabetic retinopathy.
    Yoshida-Hata N; Mitamura Y; Oshitari T; Namekata K; Harada C; Harada T; Yamamoto S
    Diabetes Res Clin Pract; 2010 Mar; 87(3):e26-8. PubMed ID: 20047772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous renin activity correlates with vascular endothelial growth factor in proliferative diabetic retinopathy.
    Kanda A; Noda K; Saito W; Ishida S
    Br J Ophthalmol; 2013 May; 97(5):666-8. PubMed ID: 23418197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.